SCHEMBL29530296

SCHEMBL29530296

C[C@H](O)OC(=O)N1CCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
ALDH1A1 P00352 7/20 0.36
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP2D6 P10635 2/20 0.33
HPGD P15428 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GAA P10253 1/20 0.32
HSD11B1 P28845 1/20 0.32
GPR119 Q8TDV5 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20424119 1.00 CYP1A2 (0.37) CYP1A2CYP2C9ALDH1A1POLBSMN1; SMN2
SCHEMBL28526308 0.95 ALDH1A1 (0.41) CYP1A2CYP2C9ALDH1A1POLBSMN1; SMN2
SCHEMBL30675350 0.95 ALDH1A1 (0.41) CYP1A2CYP2C9ALDH1A1POLBSMN1; SMN2
SCHEMBL28521203 0.95 ALDH1A1 (0.41) CYP1A2CYP2C9ALDH1A1POLBSMN1; SMN2
SCHEMBL22978699 0.93 ALDH1A1 (0.44) CYP1A2CYP2C9ALDH1A1POLBSMN1; SMN2
SCHEMBL4751832 0.91 ALDH1A1 (0.36) CYP1A2CYP2C9ALDH1A1POLBSMN1; SMN2
SCHEMBL2654623 0.84 TSHR (0.40) CYP1A2CYP2C9ALDH1A1POLBSMN1; SMN2
SCHEMBL17894913 0.81 TSHR (0.53) CYP1A2CYP2C9POLBSMN1; SMN2LMNA
SCHEMBL4751947 0.81 CA2 (0.42) CYP1A2SMN1; SMN2HSD11B1
SCHEMBL12207096 0.80 TPSAB1 (0.39) CYP1A2CYP2C9ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4217070-A1 PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER Scorpion Therapeutics, Inc. (US) 2023-08-02 EP disclosed
WO-2022066734-A1 PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER SCORPION THERAPEUTICS, INC. (US) 2022-03-31 WO disclosed